STRATEGIC DECISION-MAKING ASSISTANCE FOR
A GLOBAL FORTUNE 500 PHARMACEUTICAL FIRM
THE CHALLENGE
ADDRESSING THE CHALLENGE
The client was having difficulty objectively evaluating
market opportunities that spanned seven therapeutic
areas.
The client asked MattsonJack to construct a standardized and
reproducible strategic decision-making approach that
would prioritize market opportunities and link to the
firm's strategic planning process.
MattsonJack's industry-specific capabilities enabled it to
create a reproducible "market opportunity index"
that compared each disease area's opportunities to another's.
CLIENT FEEDBACK
The client
employed MattsonJack to update this deliverable annually
until the client acquired the internal
resources to perform the analysis.
STRATEGY
FOR AN EMERGING BIOPHARMA COMPANY: IDENTIFY AND EVALUATE COMMERCIALIZATION
OPTIONS
THE CHALLENGE
ADDRESSING THE CHALLENGE
The client had a novel compound in Phase III development.
As an emerging company with a limited commercial organization,
it needed to determine the optimal commercialization strategy
for this compound.
The client asked MattsonJack for assistance with the following:
outlining the time and resources required to create a
viable and competitive commercial infrastructure that would
enable the client to enter the U.S. market successfully
researching and analyzing commercialization options employed
by other emerging biopharmaceutical firms
identifying, analyzing and evaluating the strengths and
weaknesses of potential strategic commercialization alternatives,
taking into account significant events that might occur
before the anticipated product launch date
MattsonJack consultants used a multistep process that included:
analysis of the current and future competitive landscape
and trends in the current market, including a detailed analysis
of competitive products
evaluation of the product to determine how it most likely
would compare to current and future competitors
identification, research, profiling and analysis of commercialization
strategies employed by other emerging biopharmaceutical
companies insights obtained were employed to develop
recommended commercial organization for the client
creation of a cost of commercialization model, including
a proposed organizational structure for sales, marketing
and support personnel
promotional response analysis to refine the required optimal
resources
strategy scenario analysis, including scenario generation,
analysis and rating of commercialization alternatives using
a validated decision-analysis process
CLIENT FEEDBACK
The client's senior management was extremely
pleased with both the process and the output
specifically complimenting the comprehensiveness
of the analysis, commercial and market expertise
and continuous involvement of senior consulting
staff.
The CEO placed a high value on MattsonJack's willingness
to "push back" and challenge the client's
thinking.
The client has engaged MattsonJack on additional strategic
projects.
PRIORITIZING COMMERCIAL INVESTMENT AND IMPROVING SALES FORCE
PRODUCTIVITY
THE CHALLENGE
ADDRESSING THE CHALLENGE
The client, a regional pharmaceutical sales
and marketing company, had used MattsonJack's
services to help build its business through
in-licensing, co-promotion and product
acquisitions.
Several deals were completed. At the time
the client began considering an exit strategy,
it again asked for MattsonJack's assistance.
MattsonJack brought several suitors to the table, including two Japanese
clients that were looking for U.S. entry strategies.
MattsonJack brokered the deal, which resulted in increased value
enhancement for the owners.
CLIENT FEEDBACK
The client was purchased by a Big Pharma firm
as the nucleus for its U.S. primary care business.
The company sold for a significant, undisclosed
amount.